BANK OF AMERICA CORP /DE/ - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,102,230
-23.5%
295,794
+9.5%
0.00%0.0%
Q2 2023$7,974,929
-17.6%
270,245
-35.6%
0.00%0.0%
Q1 2023$9,673,021
+3.9%
419,836
+25.4%
0.00%0.0%
Q4 2022$9,310,009
+37.8%
334,772
+52.0%
0.00%0.0%
Q3 2022$6,758,000
+92.9%
220,217
+85.0%
0.00%
Q2 2022$3,504,000
-54.9%
119,067
-50.6%
0.00%
-100.0%
Q1 2022$7,761,000
+35.0%
241,235
+87.1%
0.00%0.0%
Q4 2021$5,751,000
+46.5%
128,948
+65.6%
0.00%
Q3 2021$3,925,000
-21.5%
77,846
+22.1%
0.00%
-100.0%
Q2 2021$5,000,000
+69.1%
63,752
+23.1%
0.00%
Q1 2021$2,956,000
-25.4%
51,771
+9.5%
0.00%
-100.0%
Q4 2020$3,961,000
+279.8%
47,294
+62.5%
0.00%
Q3 2020$1,043,000
+28.9%
29,103
-12.9%
0.00%
Q2 2020$809,000
+67.5%
33,410
+21.0%
0.00%
Q1 2020$483,000
+10.8%
27,609
+10.2%
0.00%
Q4 2019$436,000
-34.7%
25,044
-42.6%
0.00%
Q3 2019$668,000
-60.1%
43,624
-45.9%
0.00%
Q2 2019$1,675,000
-11.9%
80,664
-1.5%
0.00%
Q1 2019$1,901,000
+429.5%
81,862
+371.4%
0.00%
Q4 2018$359,000
+184.9%
17,367
+200.1%
0.00%
Q3 2018$126,000
+96.9%
5,787
+37.0%
0.00%
Q2 2018$64,000
+113.3%
4,224
+184.6%
0.00%
Q1 2018$30,000
+650.0%
1,484
+422.5%
0.00%
Q4 2017$4,0002840.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders